Equibles does not estimate personal net worth.
Get an email with a short summary when CRISPR Therapeutics AG publishes a filing, an earnings call transcript or a press release.
Get CRSP alertsRaju Prasad is recorded as CFO at CRISPR Therapeutics AG (CRSP). The newest filing on record that lists Raju Prasad as CFO at CRISPR Therapeutics AG (CRSP) is dated April 21, 2026. Raju Prasad has spoken on 1 investor event across 1 company, most recently for CRISPR Therapeutics AG on June 9, 2026. CRISPR Therapeutics AG is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CRISPR Therapeutics AG includes Samarth Kulkarni (CEO), Samarth Kulkarni, Ph.D. (Chairman), Andrew J. Silver (CFO and Chief Accounting Officer) and 7 others.
“Yeah, absolutely, and thank you for having us at the Goldman Conference once again, and it's great to be here. You know, CRISPR is now over 12 years old.”
Start not stated–present
Last confirmed April 21, 2026
Biotechnology · Healthcare
CFO
